Professional Documents
Culture Documents
2015-RB Presentation PDF
2015-RB Presentation PDF
supply performance
1
Supply – key partner in delivering RB’s strategy
2
Key facts – supply has always been ‘end–to–end’ …
3
Key facts & figures
COGS :
_ £4B
~
45 160 ~£200M
_
total capital
factories Distribution centres
(12 in health) expenditure
4
Focus on consumer health capability
5
Health manufacturing footprint in 2000
Hull
Mysore
Mauripur
6
Health manufacturing footprint in 2006
Hull
Nottingham
Bangplee
Mysore
Mauripur
7
Health manufacturing footprint in 2008
Hull
Nottingham
Fort Worth
Bangplee
Mysore
Mauripur
8
The challenge
Enhanced quality
Healthcare Greater scrutiny
GMP standards Higher compliance
Managed by household
Health plants manufacturing
& co-packers organisation
9
The solution
Greater
Reporting Enhanced investment
directly to resources behind
EVP Supply and quality technology and
compliance
10
Health manufacturing footprint in 2010 – SSL acquisition
Peterlee
Redruth Hull
Nottingham
Moscow
Fort Worth Qingdao
TTK JV1
Bangpakong
TTK JV2
TTK JV3
TTK JV4
Bangplee
Mysore
Mauripur
11
Bangpakong (Thailand) – creation of the SWB global R&D
center and Polyisoprene condoms capabilities
12
Bangpakong – global SWB R&D center
13
Bangpakong – creation of a global Polyisoprene facility
14
Leveraging assets to drive innovation: Real Feel
15
Qingdao (China) at time of acquisition
16
Qingdao now: created world class capabilities in latex condoms
17
Leveraging assets to drive innovation: Invisible
18
Applying HC capability to more acquisitions – Paras (India)
Peterlee
Redruth Hull
Nottingham
Moscow
Fort Worth Qingdao
Baddi
TTK JV1
Bangpakong
TTK JV2
TTK JV3
TTK JV4
Bangplee
Mysore
Mauripur
19
Applying new HC capability to future factories
20
Applying HC capability to more acquisitions – Schiff & Guilong
Peterlee
Shanxhi
Redruth Hull
Nottingham Anhui
Salt Lake City
Moscow
Fort Worth Qingdao
Baddi
TTK JV1
Bangpakong
TTK JV2
TTK JV3
TTK JV4
Bangplee
Mysore
Mauripur
21
Schiff – at time of acquisition – a VMS plant
22
Schiff today – conversion to OTC standards
23
Schiff – leveraging new OTC standards
MegaRed/softgels insourcing and future softgels OTC NPD
24
Focus on our healthcare capabilities
Constant upgrade
Every new license is only
of GMP/Quality
a ‘license to learn’
standards
25
Quality vision – a healthy combination of……
26
Health global manufacturing cluster – rationalisation
Peterlee
Shanxhi
Redruth Hull
Nottingham Anhui
Salt Lake City
Moscow
Fort Worth Qingdao
Baddi
TTK JV1
Bangpakong
TTK JV2
TTK JV3
TTK JV4
Bangplee
Mysore
Mauripur
27
Health global manufacturing cluster – rationalisation
Peterlee
Shanxhi
Redruth Hull
Nottingham Anhui
Salt Lake City
Moscow
Fort Worth Qingdao
Baddi
TTK JV1
Bangpakong
TTK JV2
TTK JV3
Bangplee
Chennai
Mysore
Mauripur
28
Health global manufacturing cluster – rationalisation
Peterlee
Shanxhi
Redruth Hull
Nottingham Anhui
Salt Lake City
Moscow
Fort Worth Qingdao
Baddi
TTK JV1
Bangpakong
TTK JV2
TTK JV3
Bangplee
Chennai
Mysore
Mauripur
29
Driving the earnings model
30
Driving the earnings model
Procurement Freight
Margin expansion Conversion cost Inventory losses
FUEL Logistics fixed costs
Payables Inventory
Cash CAPEX
31
Margin expansion
32
Margins – 3 years of virtuous earnings
Gross
Gross
margin
margin
+330bps
Net
Fixed
Revenue
cost
growth
Reinvest
Reinvest Operating
Operating
drive
drive margin
margin
+90bps +250bps
33
Earnings model Gross margin
Manufacturing
Global Logistics Project
Network
procurement efficiencies FUEL
Strategy
34
Project Fuel:
35
Cash
36
CAPEX & PPE - KPIs
CAPEX/NR
CAPEX/COGS
PPE/NR
PPE/COGS
37
Driving efficiency in our plants to leverage assets
Dipping process – China SWB factory Finish Quantum process – Poland ADW factory
38
CAPEX is about strategy and discipline
39
Supply – key partner in delivering RB’s strategy
40
Q&A
41
Appendix
42
On track for Vision 2020 sustainability targets
2020
Target
vs 2012 baseline
ISO 14001 certification GMS compliance
2020
Target
43